CompaniesGeNeuro

GeNeuro

active
Geneva, Switzerland
Founded 2006
Website
About

CNS drugs

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

826

By Phase

PHASE2: 3NA: 2

By Status

COMPLETED: 4TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT04562376
Hover over trial bars to see details

Recent Trials

NCT05497089Lead Sponsor
Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome
PHASE2Completed
203 participants
Started: Aug 29, 2022 · Completed: May 10, 2024
NCT04562376Collaborator
High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue
NACompleted
73 participants
Started: Aug 20, 2020 · Completed: Jun 30, 2022
NCT03239860Lead Sponsor
Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis
PHASE2Terminated
220 participants
Started: Jun 6, 2017 · Completed: Nov 14, 2018
NCT02782858Lead Sponsor
Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS
PHASE2Completed
270 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2017
NCT02642055Lead Sponsor
Efficacy of Neuro+ Attention Training
NACompleted
60 participants
Started: Dec 31, 2015 · Completed: Oct 31, 2016
Locations (1)
Headquarters
Geneva, Switzerland
Map

Loading map...